Finding new anticancer agents from bacterial natural products
Discovery and characterization of synthetic bioinformatic natural product anticancer agents
This study is looking for new cancer-fighting medicines made from natural substances found in bacteria, hoping to find unique treatments that could help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rockefeller University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11081664 on NIH RePORTER |
What this research studies
This research focuses on discovering and characterizing new anticancer agents derived from bacterial natural products. By utilizing advanced bioinformatics and genomic analyses, the team aims to unlock previously inaccessible metabolites encoded by the global microbiome. This approach seeks to identify unique compounds that could serve as effective treatments for cancer, moving beyond traditional methods that often overlook the vast potential of microbial diversity. Patients may benefit from innovative therapies that arise from these novel compounds.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who are seeking new treatment options.
Not a fit: Patients with non-cancerous conditions or those who have exhausted all treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective anticancer therapies.
How similar studies have performed: Other research has shown promise in utilizing bacterial natural products for drug development, indicating a strong potential for success in this area.
Where this research is happening
New York, United States
- Rockefeller University — New York, United States (Active)
Researchers
- Principal investigator: Brady, Sean F — Rockefeller University
- Study coordinator: Brady, Sean F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.